Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ADYEN N.V. EO-,01 | 1N8 | Oct 3, 2024 | 1 341.80 | -0.61 |
Adyen N.V. Unsponsored ADR (Netherlands) | 1N8U | Oct 3, 2024 | 13.10 | -1.50 |
Adyton Resources Corporation | 701 | Oct 3, 2024 | 0.12 | +4.31 |
AECI Ltd | A7Z | Oct 3, 2024 | 5.20 | 0.00 |
AECOM | E6Z | Oct 3, 2024 | 92.00 | +0.55 |
Aecon Group Inc. | 2AE | Oct 3, 2024 | 13.90 | -0.71 |
Aedas Homes S.A.U. | 1QK | Oct 3, 2024 | 25.20 | +1.41 |
Aedifica SA | AOO | Oct 3, 2024 | 61.85 | -1.04 |
Aeffe | 3A1 | Oct 3, 2024 | 0.79 | -0.50 |
AEGA ASA NK 1 | 82T0 | Oct 3, 2024 | 0.01 | +16.13 |
Aegean Airlines S.A. | 32A | Oct 3, 2024 | 10.41 | -2.07 |
Aegirbio | 52Q | Oct 3, 2024 | 0.02 | -4.09 |
Aegis Brands Inc. | 6I9 | Oct 3, 2024 | 0.26 | -0.77 |
AEGON LTD. | J060 | Oct 3, 2024 | 5.50 | -2.21 |
Aegon N.V ADR | J06 | Oct 3, 2024 | 5.60 | -0.89 |
Aehr Test Systems | AYB | Oct 3, 2024 | 11.07 | +1.93 |
Aelis Farma S.A. | 69O | Oct 3, 2024 | 4.12 | -2.83 |
Aemetis, Inc | DW51 | Oct 3, 2024 | 2.33 | +14.09 |
Aena S.M.E. S.A. | A44 | Oct 3, 2024 | 197.70 | +0.97 |
Aena SME S.A. American Depositary Receipts - Unsponsored | A440 | Oct 3, 2024 | 18.70 | +1.08 |
AEON CO. LTD ADR/1 O.N. | JUS | Oct 3, 2024 | 23.00 | -1.71 |
Aeon Co. Ltd. | JUS1 | Oct 3, 2024 | 24.00 | -0.83 |
Aeon Financial Service Co Ltd. | 67J | Oct 3, 2024 | 7.65 | -1.92 |
Aeon Mall Co | 9DH | Oct 3, 2024 | 12.80 | 0.00 |
Aeon Metals Limited | D6V1 | Oct 3, 2024 | 0.00 | 0.00 |
AEON REIT INVESTMEN.CORP. | HB0 | Oct 3, 2024 | 798.50 | -1.02 |
AEON STORES | AVK1 | Oct 3, 2024 | 0.03 | 0.00 |
Aequus Pharmaceuticals Inc | AEQ | Oct 3, 2024 | 0.01 | 0.00 |
AerCap Holdings N.V. Ordinary Shares | R1D | Oct 3, 2024 | 83.40 | -0.41 |
AERO ENERGY LTD. | UU3 | Oct 3, 2024 | 0.03 | +1.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.